^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

The effect of eribulin treatment for patients with HER2-low breast cancer

Published date:
12/02/2023
Excerpt:
In this study, we investigated the effect of eribulin for patients with HER2-low breast cancer….In HR-negative/HER2-low group, PFS was improved by eribulin treatment...